MedPath

Clinical trial to study the effect of Madhutailika Basti on immunoglobulin-G in Type II Diabetes mellitus

Not Applicable
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2021/01/030497
Lead Sponsor
SDM College of Ayurveda and Hospital Hassan Karnataka
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient fulfilling the diagnostic criteria of Prameha.

Patients fit for Basti Karma.

Patients with clinical positive history of Type II Diabetes for 5 to 10 years.

Patients who give informed consent.

Exclusion Criteria

Patients with PPBS >320mg/dl, HbA1C above 10.

History of frequent and/ severe allregic reactions with multiple medications.

Diagnosed cases of other Endocrine and Metabolic disorders.

Patients with Type I DM, Infectious diseases, Malignancy.

Chain smokers, alcoholics, pregnant and lactating women.

Patients unsuitable for Basti karma.

Patients with other diabetic complications like Nephropathy, Diabetic Heart Disease, Ketoacidosis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in the sign and symptoms of Type II DiabetesTimepoint: 0th, 9th, 25th and 40th day
Secondary Outcome Measures
NameTimeMethod
Immunoglobulin G Values, FBS, PPBSTimepoint: 0th, 9th, 25th and 40th day
© Copyright 2025. All Rights Reserved by MedPath